PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat cancers in phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called IBI343 combined with other treatments for people with advanced stomach or pancreatic cancers that have a specific marker (CLDN18.2). The goal is to see if the combination is safe and can shrink tumors. About 389 adults with these cancers will ta…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Apr 29, 2026 01:52 UTC
-
Gene test hope for advanced cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether doing genetic testing early, instead of later, can help find better treatments for people with advanced breast, liver, or pancreatic cancer. About 360 adults with poor-prognosis cancers will be randomly assigned to early or standard genetic testing. Th…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:51 UTC